{"transactions":[{"id":790150,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":false,"shares":3031578,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":965255},"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":790149,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":false,"shares":8421052,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2681265},"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":790148,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":false,"shares":40000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12736014},"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":790147,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":true,"shares":965255,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":16685013,"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":790146,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":true,"shares":2681265,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":15719758,"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":790145,"issuer":{"id":4799,"kind":"organization","name":"Seaport Therapeutics, Inc."},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49414,"kind":"organization","name":"PureTech LYT, Inc.","position":2,"cik":"0002131815","reported_name":"PureTech LYT, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T23:38:15.000Z","date":"2026-05-04","kind":"exercise","planned":false,"acquired":true,"shares":12736014,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1, Series A-2 and Series B Preferred Stock (collectively, the \"Preferred Stock\") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech LYT, Inc. is the record holder of all of the securities reported in this Form 4. PureTech Health LLC is the sole owner of PureTech LYT, Inc. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech LYT, Inc. and PureTech Health LLC."}],"balance_after":13038493,"source":{"system":"sec-edgar","filing":"0001193125-26-209701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042347/000119312526209701/ownership.xml","form_type":"4"}},{"id":1458373,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T19:42:32.000Z","date":"2024-07-02","kind":"other","planned":false,"acquired":false,"shares":12527477,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of shares of common stock (each, a \"Share\") of the Issuer at a price per Share of $0.4340 (the \"Offer Price\") pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 29, 2024, by and among the Issuer, Virtual Therapeutics Corporation, a Delaware corporation (\"Parent\"), and Alpha Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"). Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer, effective as of July 2, 2024 (the \"Effective Time\"), with the Issuer surviving the merger. As of the Effective Time, each Share held by the Reporting Person was converted into the Offer Price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech Health LLC is the record holder of all of the securities reported in this Form 4. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech Health LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-082232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850266/000095017024082232/ownership.xml","form_type":"4"}},{"id":1775464,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-09-21T16:30:07.000Z","date":"2023-09-20","kind":"purchase","planned":false,"acquired":true,"price":1500000,"reported_value":1500000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0494,"exercise_date":"2023-09-20","expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":30364372},"source":{"system":"sec-edgar","filing":"0000950170-23-049198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023049198/ownership.xml","form_type":"4"}},{"id":1855988,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-06-14T16:30:15.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"price":3000000,"reported_value":3000000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0134,"exercise_date":"2023-06-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":223880597},"source":{"system":"sec-edgar","filing":"0000899243-23-015533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323015533/doc4.xml","form_type":"4"}},{"id":1873403,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-31T17:30:09.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":43133803,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein."}],"balance_after":43133803,"derivative":{"exercise_price":0.0142,"exercise_date":"2023-05-26","expiration_date":"2028-05-26","underlying":"Common Stock","underlying_shares":43133803},"source":{"system":"sec-edgar","filing":"0000899243-23-014169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323014169/doc4.xml","form_type":"4"}},{"id":1873402,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-31T17:30:09.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"price":350000,"reported_value":350000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0142,"exercise_date":"2023-05-26","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":24647887},"source":{"system":"sec-edgar","filing":"0000899243-23-014169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323014169/doc4.xml","form_type":"4"}},{"id":1906263,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":192307692,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein"}],"balance_after":192307692,"derivative":{"exercise_price":0.0182,"exercise_date":"2023-05-01","expiration_date":"2028-05-01","underlying":"Common Stock","underlying_shares":192307692},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906262,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":23688047,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Note and Warrant Purchase Agreement, on February 21, 2023, the Issuer issued to PureTechHealth LLC convertible notes in an aggregate principal amount of $5,000,000 as well as warrants to purchase 23,688,047 shares of common stock. At the time of issuance, both the conversion of the convertible notes and exercise of the warrants was subject to the Issuer first receiving stockholder approval for the issuance of the underlying shares of common stock. On May 1, 2023, the Issuer and the Reporting Persons amended the terms of the convertible notes and warrants to remove this restriction on conversion and exercise, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein"}],"balance_after":23688047,"derivative":{"exercise_price":0.2744,"exercise_date":"2023-05-01","expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":23688047},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906261,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":2000000,"value":4000000000000.0,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares underlying the convertible notes reported herein is based on the outstanding principal amount plus accrued and unpaid interest as of April 30, 2023, and such number is subject to adjustment in accordance with the terms of the convertible notes."}],"balance_after":2000000,"derivative":{"exercise_price":0.0182,"exercise_date":"2023-05-01","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":109890110},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906260,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":5000000,"price":5000000,"value":25000000000000.0,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Note and Warrant Purchase Agreement, on February 21, 2023, the Issuer issued to PureTechHealth LLC convertible notes in an aggregate principal amount of $5,000,000 as well as warrants to purchase 23,688,047 shares of common stock. At the time of issuance, both the conversion of the convertible notes and exercise of the warrants was subject to the Issuer first receiving stockholder approval for the issuance of the underlying shares of common stock. On May 1, 2023, the Issuer and the Reporting Persons amended the terms of the convertible notes and warrants to remove this restriction on conversion and exercise, respectively."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares underlying the convertible notes reported herein is based on the outstanding principal amount plus accrued and unpaid interest as of April 30, 2023, and such number is subject to adjustment in accordance with the terms of the convertible notes."}],"balance_after":5000000,"derivative":{"exercise_price":0.2744,"exercise_date":"2023-05-01","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":18634597},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}}]}